These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31065736)

  • 1. [The role of biostatistics in institutional review boards].
    Schlattmann P; Scherag A; Rauch G; Mansmann U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jun; 62(6):751-757. PubMed ID: 31065736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethics in a scientific approach: the importance of the biostatistician in research ethics committees.
    Atici E; Erdemir AD
    J Med Ethics; 2008 Apr; 34(4):297-300. PubMed ID: 18375684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive survey among statistical members of medical ethics committees in Germany on their personal impression of completeness and correctness of biostatistical aspects of submitted study protocols.
    Rauch G; Hafermann L; Mansmann U; Pigeot I
    BMJ Open; 2020 Feb; 10(2):e032864. PubMed ID: 32024788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical issues in oncology biostatistics.
    Thall PF
    Stat Methods Med Res; 2002 Oct; 11(5):429-48. PubMed ID: 12357588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of the institutional review boards in Korea: constitution, operation, and policy for protection of human research participants.
    Kim OJ; Park BJ; Sohn DR; Lee SM; Shin SG
    J Korean Med Sci; 2003 Feb; 18(1):3-10. PubMed ID: 12589079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistencies in institutional review board decisions: A proposal to regulate the decision-making process.
    Ekmekci PE; Guner MD
    Bratisl Lek Listy; 2019; 120(2):95-101. PubMed ID: 30793611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional review board guidance on pediatric research: missed opportunities.
    Wolf LE; Zandecki J; Lo B
    J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Institutional Review Boards (IRBs) on Clinical Innovation: A Survey of Investigators and IRB Members.
    Stryjewski TP; Kalish BT; Silverman B; Lehmann LS
    J Empir Res Hum Res Ethics; 2015 Dec; 10(5):481-7. PubMed ID: 26564945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Knopman D; Alford E; Tate K; Long M; Khachaturian AS
    Alzheimers Dement; 2017 Aug; 13(8):940-946. PubMed ID: 28709585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biostatistical collaboration in medical research.
    Ellenberg JH
    Biometrics; 1990 Mar; 46(1):1-18; discussion 19-32. PubMed ID: 2190637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality Assessment of Institutional Review Board Activity by Nonscientific/Nonaffiliated Members.
    Shin S; Kim MA
    Clin Lab; 2016; 62(3):483-7. PubMed ID: 27156340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should society allow research ethics boards to be run as for-profit enterprises?
    Emanuel EJ; Lemmens T; Elliot C
    PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementing the traditional institutional review board with an environmental health and community review board.
    Gilbert SG
    Environ Health Perspect; 2006 Oct; 114(10):1626-9. PubMed ID: 17035155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistency and institutional review boards.
    Goldman J; Katz MD
    JAMA; 1982 Jul; 248(2):197-202. PubMed ID: 7045428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of multicenter studies by multiple institutional review boards: characteristics and outcomes for perinatal studies implemented by a multicenter network.
    Abramovici A; Salazar A; Edvalson T; Gallagher N; Dorman K; Tita A;
    Am J Obstet Gynecol; 2015 Jan; 212(1):110.e1-6. PubMed ID: 25088862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Justification and authority in institutional review board decision letters.
    Clapp JT; Gleason KA; Joffe S
    Soc Sci Med; 2017 Dec; 194():25-33. PubMed ID: 29059597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and wrongs in social science research. An evaluator's guide to the IRB.
    Oakes JM
    Eval Rev; 2002 Oct; 26(5):443-79. PubMed ID: 12243104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding institutional review boards: practical guidance to the IRB review process.
    Pech C; Cob N; Cejka JT
    Nutr Clin Pract; 2007 Dec; 22(6):618-28. PubMed ID: 18042949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.